CATALYST PHARMACEUTICALS INC (CPRX)

US14888U1016 - Common Stock

14.89  +0.21 (+1.43%)

After market: 14.89 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
398.20M214.20M140.80M119.10M102.30M
Cost Of Goods
51.97M34.40M21.90M17.00M14.80M
Gross Profit
346.24M179.80M118.90M102.00M87.50M
Operating Expenses
259.43M78.00M66.50M60.80M55.70M
Research and Development
93.15M19.80M16.90M16.50M18.80M
Selling, General, and Administrative Expenses
133.71M58.20M49.60M44.20M36.90M
Operating Income
86.81M101.80M52.40M41.30M31.80M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
7.70M2.90M300.00K600.00K1.60M
Income Before Taxes
94.51M104.70M52.70M41.90M33.40M
Income Tax
23.10M21.60M13.20M-33.10M1.50M
Net Income
71.41M83.10M39.50M75.00M31.90M
EBITDA
119.69M103.00M52.60M41.40M31.90M
 
Per Share Data
EPS Diluted Total Ops
0.630.750.370.710.30
Non GAAP EPS
0.810.740.370.410.30
 
Statistics
Gross Profit Margin
86.95%83.94%84.45%85.64%85.53%
Profit Margin
17.93%38.80%28.05%62.97%31.18%
Operating Profit Margin
21.80%47.53%37.22%34.68%31.09%

All data in USD

Charts